Loading clinical trials...
Loading clinical trials...
The Cardiac Lead Assessment Study (CLAS) is designed as a prospective, non-randomized, multi-center, international postmarket surveillance study under 522 Order PS120111 (August 16, 2012).
The objective of this study was to determine the prevalence and incidence of externalized conductors and other visual lead anomalies (as evidenced by imaging) and the risk of progression to electrical dysfunction in subjects with one or more of the following St. Jude Medical (SJM) cardiac leads: Riata leads, Riata ST leads, Durata and/or QuickSite/QuickFlex Cardiac Resynchronization Therapy (CRT) leads.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Cardiology, P.C.
Birmingham, Alabama, United States
University Hospital of Alabama at Birmingham
Birmingham, Alabama, United States
Heart Center Research
Huntsville, Alabama, United States
Arizona Arrhythmia Consultants
Scottsdale, Arizona, United States
Arkansas Heart Hospital
Little Rock, Arkansas, United States
Scripps Green Hospital
La Jolla, California, United States
Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
Cardiac Rhythm Specialists
Reseda, California, United States
Mercy Medical Group
Sacramento, California, United States
St. Joseph's Medical Center
Stockton, California, United States
Start Date
March 1, 2013
Primary Completion Date
June 1, 2019
Completion Date
September 1, 2019
Last Updated
August 23, 2021
2,216
ACTUAL participants
Implanted with one or more of the following SJM leads: Riata leads, RiataST leads, Durata leads, and QuickSite/QuickFlex leads
DEVICE
Lead Sponsor
Abbott Medical Devices
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions